Nautilus Biotechnology, Inc. (NAUT) stock
NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$2.36+0.26 (+12.38%)
Close on Nov 17, 2026Market cap $300.60MP/E –Yield –
Nautilus Biotechnology operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nautilus Biotechnology's operating cash flow for the twelve months ending Sep 30, 2026 was -$52.48M. For fiscal 2025 it was -$50.70M. The highest annual figure on record is -$14.00M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$50.70M | – |
| FY2024 | Dec 31, 2024 | -$59.15M | – |
| FY2023 | Dec 31, 2023 | -$51.71M | – |
| FY2022 | Dec 31, 2022 | -$45.81M | – |
| FY2021 | Dec 31, 2021 | -$39.24M | – |
| FY2020 | Dec 31, 2020 | -$14.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$13.28M | – |
| Q2 FY2026 | Jun 30, 2026 | -$13.73M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.38M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.03M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.94M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.31M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.11M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.46M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.90M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.74M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.52M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.53M | – |
| Q1 FY2022 | Mar 31, 2022 | -$12.34M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.29M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.25M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.73M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.37M | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
See a number that looks wrong?